Skip to main content

Advertisement

Table 1 Clinical characteristics describing the study participants

From: Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

  Number Percentage
Patients 211* 100
Age at first sampling year, mean ± SD 73.0 ± 8.91  
Tumor stage at diagnosis
 T1/2 44 20.9
 T3/4 50 23.7
 M1 74 35.1
 Node-positive 15 7.1
 Not specified 28 13.3
Gleason score at diagnosis
 ≤ 7 72 34.1
 8–10 108 51.2
 Not specified 31 14.7
Primary treatment
 ADT (± RT/CT) 125 59.2
 Radical Px (± RT) 61 28.9
 Radical Px + ADT 7 3.3
 Other 18 8.5
Metastatic burden at first sampling
 LN only 31 14.7
 Bone only 73 34.6
 Bone and LN 61 28.9
 Visceral and bone and/or LN 34 16.1
 Not specified 12 5.7
Stage at first sampling (all patients, n = 217)
 mHNPC 23 10.6
 mHSPC1 6 2.8
 mCRPC 188 86.6
  1. *Six individuals declined access to medical records